Hepatitis C infection in patients undergoing liver retransplantation

Transplantation

Volumn 66, Issue 12, 1998, Pages 1612-1616

  Rosen, Hugo R ^b   Martin, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GRAFT FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERBILIRUBINEMIA; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; REOPERATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032573676     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00007     Document Type: Article

References (24)

1. Rosen HR, Shackleton CR, Martin P. Indications for and timing of orthotopic liver transplantation. Med Clin North Am 1996; 80: 1069.
2. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16: 865.
3. Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65: 1178.
4. Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid SV et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62: 1773.
5. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
6. Casavilla FA, Lee R, Lim J, et al. Outcome of liver retransplantation for recurrent hepatitis C infection. Hepatology 1995; 22: 153A.
7. Feray C, Habsanne A, Samuel D, Farges O, Reynes M, Bismuth H. Poor prognosis of patients retransplanted for recurrent liver disease due to hepatitis C virus. Hepatology 1995; 22: 135A.
8. Carithers RL. Recurrent hepatitis C after liver transplantation. Liver Transplant Surg 1997; 3: S16.
9. Wong T, Devlin J, Rolando N, Heaton N, Williams R. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation 1997; 64: 878.
10. Ploeg RJ, D'Allessandro Am, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55: 807-813.
11. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829.
12. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119.
13. VanThiel DH, Wright HI, Faguiuoli S: Liver transplantation for hepatitis B virus-associated cirrhosis: a progress report. Hepatology 1994; 20: 20S.
14. Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H: Retransplantation in hepatitis B: a multicenter experience. Transplantation 1994; 57: 823.
15. Ishitani M, McGory R, Dickson R, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997; 64: 410.
16. Lau JYN, Bain VG, Smith HM, et al. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 1992; 53: 894.
17. Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61: 402.
18. Rosen HR, Martin P. OKT3 and hepatitis C: defining the risks. Transplantation 1997; 63: 171.
19. Sheiner PA, Schluger LK, Emre S, et al. Retransplantation for recurrent HCV. Liver Transplant Surg 1997; 3: 130.
20. Doyle HR, Morelli F, McMichael J, et al. Hepatic retransplantation: an analysis of risk factors associated with outcome. Transplantation 1996; 61: 1499.
21. Clements WD, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 1993; 128: 200.
22. Schluger LK, Sheiner PA, Thung SW, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971.
23. Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology (in press).
24. Rosen HR, Blake M, Houghton M, et al. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation [Abstract]. Gastroenterology 1998; 114(4, part 2): abstract L0536.